scispace - formally typeset
Open AccessJournal ArticleDOI

Cognitive impairment in patients with AIDS - prevalence and severity.

TLDR
The severity and prevalence of the neuropsychiatric complications of HIV including delirium, neurobehavioral impairments (depression), minor cognitive-motor dysfunction, and HIV-associated dementia are reviewed.
Abstract
The advent of highly active antiretroviral therapy has prolonged the life expectancy of HIV patients and decreased the number of adults who progress to AIDS and HIV-associated dementia. However, neurocognitive deficits remain a pronounced consequence of HIV/AIDS. HIV-1 infection targets the central nervous system in subcortical brain areas and leads to high rates of delirium, depression, opportunistic central nervous system infections, and dementia. Long-term HIV replication in the brain occurs in astrocytes and microglia, allowing the virus to hide from antiviral medication and later compromise neuronal function. The associated cognitive disturbance is linked to both viral activity and inflammatory and other mediators from these immune cells that lead to the damage associated with HIV-associated neurocognitive disorders, a general term given for these disturbances. We review the severity and prevalence of the neuropsychiatric complications of HIV including delirium, neurobehavioral impairments (depression), minor cognitive-motor dysfunction, and HIV-associated dementia.

read more

Content maybe subject to copyright    Report

Citations
More filters
Journal ArticleDOI

Future challenges for clinical care of an ageing population infected with HIV: a modelling study

TL;DR: The profile of patients in the Netherlands infected with HIV is changing, with increasing numbers of older patients with multiple morbidities, which means that, in the near future, HIV care will increasingly need to draw on a wide range of medical disciplines, in addition to evidence-based screening and monitoring protocols to ensure continued high-quality care.
Journal ArticleDOI

Immortalization of primary microglia: a new platform to study HIV regulation in the central nervous system

TL;DR: The immortalized cells have microglia-like morphology and express key microglial surface markers including CD11b, TGFβR, and P2RY12 and demonstrate the expected migratory and phagocytic activity, and the capacity to mount an inflammatory response characteristic of primarymicroglia.
Journal ArticleDOI

Cognitive Impairment in people living with HIV in the ART era: A Review.

TL;DR: This review is based on recent published literature in the field of HIV-associated cognitive impairment (HAND) and focuses on the role of psychiatric diseases, such as depression, in the development and maintenance of HAND.
Journal ArticleDOI

Neurotoxicity in the Post-HAART Era: Caution for the Antiretroviral Therapeutics.

TL;DR: The particular emphasis of this review is to highlight the need to identify alternative approaches in reducing the CNS toxicity of the ARV drugs in HIV-infected individuals.
References
More filters
Journal ArticleDOI

Identification of a Reservoir for HIV-1 in Patients on Highly Active Antiretroviral Therapy

TL;DR: In a study of 22 patients successfully treated with HAART for up to 30 months, replication-competent virus was routinely recovered from resting CD4+ T lymphocytes, and generally did not show mutations associated with resistance to the relevant antiretroviral drugs.
Journal ArticleDOI

The brain in AIDS: central nervous system HIV-1 infection and AIDS dementia complex

TL;DR: Within the context of the permissive effect of immunosuppression, genetic changes in HIV-1 may underlie the neuropathological heterogeneity of the AIDS dementia complex and its relatively independent course in relation to the systemic manifestations of AIDS noted in some patients.
Related Papers (5)